<DOC>
	<DOCNO>NCT01707641</DOCNO>
	<brief_summary>Oral mucositis debilitate side effect oncology patient clear need new therapeutic option . The lozenge contain Lactobacillus brevis CD2 prove potential new alternative prevention grade III IV mucositis . The main endpoint study verify lozenges take 6 time day may reduce incidence grade III IV mucositis well increase percentage patient complete radio-chemotherapy treatment .</brief_summary>
	<brief_title>Effect Lactobacillus Brevis CD2 Prevention Radio-chemotherapy Induced Oral Mucositis Head Neck Cancer</brief_title>
	<detailed_description>Mucositis debilitate side effect radio chemotherapy treatment oncology patient . It painful , also limit adequate nutritional intake decrease willingness patient continue treatment . Furthermore , extensive mucositis may require additional nutritional supplementation , narcotic analgesic increase cost therapy . Quality life impair patient develop severe mucositis . Clinically , begin asymptomatic redness erythema ultimately pass different stage large acutely painful contiguous pseudomembranous lesion associate dysphagia decrease oral intake . The common sit oral mucositis labial , buccal , soft palate , floor mouth , ventral surface tongue . The loss epithelial cell expose underlie connective tissue associate innervation cause pain . Oral infection , may due bacterial , fungal , virus may exacerbate mucositis well lead systemic infection . Treatment prevention therapy relate mucositis essential ; unfortunately , efficacy safety regimen use clearly establish . Prophylactic measure employ use : chlorhexidine , saline rinse , soda bicarbonate rinse , acyclovir , ice . For treatment mucositis associate pain local anesthetic , diphenhydramine , nystatin , sucralfate use alone combination mouthwash . Oral parenteral narcotic also use pain relief . There clear need new therapeutic option oral mucositis .</detailed_description>
	<mesh_term>Head Neck Neoplasms</mesh_term>
	<mesh_term>Mucositis</mesh_term>
	<mesh_term>Stomatitis</mesh_term>
	<criteria>male female patient &gt; 18 year age Karnofsky Performance Status &gt; 70 % pathological histological diagnosis confirms head neck tumour patient eligible radical radiotherapy and/or chemotherapy expect survival time &gt; 6 month normal bone marrow function ( neutrophil count &gt; 1500/cmm , platelet count &gt; 100.000/CMM ) serum creatine &lt; 1.8mg/dl total bilirubin &lt; 2mg/dl GOT , GPT within 3 time normal limit willingness perform conventional 3D radiotherapy intensive modulate radiation therapy concurrent chemotherapy sign informed consent form 1 . Diagnosis glottic tumour , parotid salivary , larynx tumour . 2 . Presence metastasis , detect contrastenhances TC TB and/or PET/TC 3 . Major surgery oral cavity within last 4 week 4 . Patients previoucly treat radiotherapy head neck 5 . Antifungal antiviral therapy oral pathological condition last 6 . Other serious concomitant disease 7 . History insulindependent Diabetes Mellituss 8 . History oral ulceration , herpes simplex , oral candidiasis , severe gingivitis , active chronic mucositis Xerostomia 9 . Patients body weigh &gt; 35 kg 10 . Women childbearing potential pregnant , breastfeed intend become pregnant 11 . Patients Hepatitis B / C 12 . Patients symptomatic untreated dental infection 13 . Patients oral mucositis grade NCICTC 3 4 14 . Histological pathological diagnosis unavailable 15 . Patients sign symptom systemic infection 16 . Patient 's refusal sign inform consent</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2014</verification_date>
</DOC>